Breast cancers that have human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) scores of 1+ or 2+ with negative in-situ hybridization (ISH) represent around 50% of breast cancers. As research continues to explore this population of patients, which exist within the clinically negative HER2 classification, the pathologist’s approach to scoring HER2 across this complete spectrum may need to be revisited.
This comprehensive short course aims to support pathologists with distinguishing and differentiating discrete IHC scores, using a combination of short presentations and focused virtual microscopy tutorials utilizing clinical cases. Together, the three sessions will reinforce current scoring guidelines, identify opportunities to standardize testing and scoring practices, demonstrate approaches to scoring challenging cases, and showcase best practice recommendations.
To view similar clinical cases featured in this series and browse a collection of over 100 hand-selected slides, please visit HER2Know.com– a peer-led clinical education portal supporting pathologists with the evolving need in HER2 expressing breast cancer.
The information presented represents the opinion of the presenters and is not necessarily the view of USCAP. USCAP does not endorse the products or services. The webinar is possible through a sponsorship from AstraZeneca and Daiichi Sankyo. This activity is not available for CME.
All courses will start at 11:00 AM Pacific Time.
Practicing academic and community pathologists, and pathologists-in-training.
Upon completion of this activity, learners will able to:
Presenters were compensated for their time.
Marilyn Bui, MD, PhD
Senior Member and Profession in the Department of Pathology, Moffitt Cancer Center & Research Institute
Michael Feldman, MD, PhD
Professor of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine
David Hicks, MD
Tenured Professor of Pathology, University of Rochester Medical Center
Shabnam Jaffer, MD
Professor of Pathology, Molecular and Cell Based Medicine, The Icahn School of Medicine at Mount Sinai
Thaer Khoury, MD
Vice Chair of Anatomic Pathology, Chief of Breast Pathology, Roswell Park Comprehensive Cancer Center
Savitri Krishnamurthy, MD
Professor of Pathology, The University of Texas MD Anderson Cancer Center
Gary Tozbikian, MD
Associate Professor and Breast Pathology Division Director, The Ohio State University Wexner Medical Center
Shi Wei, MD, PhD
Professor of Pathology and Laboratory Medicine, The Barbara F. Atkinson Endowed Professor, Director of Translational Research, University of Kansas Medical Center
Hannah Wen, MD, PhD
Director, Breast Pathology Fellowship, Memorial Sloan Kettering Cancer Center
The webinar is possible through a sponsorship from AstraZeneca and Daiichi Sankyo. This content is not available for continuing medical education. If you continue to register, you are acknowledging that your information will be shared with the company, including your name, degrees, institution, NPI number, mailing address, email address, and phone number. USCAP has no control over the use of this information and encourages you to review their privacy policies.
This course is free.
Please use the code HER2Know at checkout.